نتایج جستجو برای: hpv vaccine

تعداد نتایج: 124304  

Journal: :Pediatrics 2014
Monica Sull Joanna Eavey Vikki Papadouka Rebecca Mandell Michael A Hansen Jane R Zucker

OBJECTIVES To investigate adolescent vaccination in New York City, we assessed tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal conjugate (MCV4), and human papillomavirus (HPV) vaccine uptake, vaccine co-administration, and catch-up coverage over time. METHODS We analyzed data from the Citywide Immunization Registry, a population-based immunization information system, to mea...

Journal: :Journal of women's health 2016
Kimberly A Kilfoyle Lisa Rahangdale Stacie B Dusetzina

BACKGROUND Young adult women find it acceptable to be offered the human papillomavirus (HPV) vaccine postpartum. Little is known about the practice of administering the HPV vaccine during the postpartum period. MATERIALS AND METHODS The Truven Health Analytics MarketScan Commercial Claims and Encounters database was used to develop a cohort of privately insured 18 to 26-year-old women with un...

Journal: :Social science & medicine 2009
Paul L Reiter Noel T Brewer Sami L Gottlieb Annie-Laurie McRee Jennifer S Smith

Though many studies have documented correlates of HPV vaccine acceptability, our study is one of the first to examine correlates of vaccine initiation. The current study aimed to identify modifiable correlates of HPV vaccine initiation among adolescent girls in high risk communities and whether correlates varied by race and urban/rural status. In 2007, we conducted a cross-sectional survey of 8...

Journal: :The journal of family planning and reproductive health care 2011
Kate Williams Alice Forster Laura Marlow Jo Waller

Background and methodology This study explored knowledge about human papillomavirus (HPV) and attitudes towards HPV vaccination among girls who were part of the 'catch-up' vaccination programme. Interviews were carried out between March and May 2009 with girls (aged 17-18 years) who had received HPV vaccine (n=5) and girls who had opted not to receive HPV vaccine (n=5). Interviews lasted approx...

2004
Lydia Ogden Jessica Ogden Promise Mthembu Nancy Williamson

particles (VLPs). Species-specific VLP vaccines provide protection against infection and disease. Protection was associated with the development of neutralizing antibodies. Serum from vaccinated animals conferred protection to unvaccinated animals. The HPV-6, HPV-11, HPV-16, and HPV-18 L1 VLP vaccine is manufactured in Saccharomyces cerevisiae (yeast), and yeast-derived vaccines have been given...

2014
Heidi J Larson Rose Wilson Sharon Hanley Astrid Parys Pauline Paterson

UNLABELLED In June 2013 the Japanese Ministry of Health, Labor, and Welfare (MHLW) suspended its HPV vaccination recommendation after a series of highly publicized alleged adverse events following immunization stoked public doubts about the vaccine's safety. This paper examines the global spread of the news of Japan's HPV vaccine suspension through online media, and takes a retrospective look a...

2010
Young-Jae Kim Kyung-Tai Kim Jae-Hoon Kim Soon-Do Cha Jae Weon Kim Duk-Soo Bae Joo-Hyun Nam Woong-Shick Ahn Ho-Sun Choi

The human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine has been demonstrated to be highly efficacious and immunogenic with a favorable safety profile. This study assessed the immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Korean girls aged 10-14 yr. This multi-center, observer-blind trial randomly assigned 321 healthy girls to receive three d...

2014
Shannon Stokley Jenny Jeyarajah David Yankey Maria Cano Julianne Gee Jill Roark C. Robinette Curtis Lauri Markowitz

Since mid-2006, a licensed human papillomavirus (HPV) vaccine has been available and recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescent girls at ages 11 or 12 years. Two vaccines that protect against HPV infection are currently available in the United States. Both the quadrivalent (HPV4) and bivalent (HPV2) vaccines protect against HPV t...

2014
Feng-Cai Zhu Wen Chen Yue-Mei Hu Ying Hong Juan Li Xun Zhang Yi-Ju Zhang Qin-Jing Pan Fang-Hui Zhao Jia-Xi Yu Yan-Shu Zhang Xiaoping Yang Cheng-Fu Zhang Haiwen Tang Helen Zhang Marie Lebacq Marie-Pierre David Sanjoy K Datta Frank Struyf Dan Bi Dominique Descamps

This phase II/III, double-blind, randomized trial assessed the efficacy, immunogenicity and safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in young Chinese women (ClinicalTrials.gov registration NCT00779766). Women aged 18-25 years from Jiangsu province were randomized (1:1) to receive HPV vaccine (n = 3,026) or Al(OH)3 control (n = 3,025) at months 0, 1 and 6. The prima...

Journal: :International journal of cancer 2008
Gonzalo Perez Eduardo Lazcano-Ponce Mauricio Hernandez-Avila Patricia J García Nubia Muñoz Luisa L Villa Janine Bryan Frank J Taddeo Shuang Lu Mark T Esser Scott Vuocolo Carlos Sattler Eliav Barr

The prevalence of HPV infection in Latin America is among the highest in the world. A quadrivalent (types 6/11/16/18) human papillomavirus L1 virus-like-particle vaccine has been shown to be 95-100% effective in preventing HPV 6/11/16/18-related cervical and genital disease in women naive to vaccine HPV types. A total of 6,004 female subjects aged 9-24 were recruited from Brazil, Mexico, Colomb...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید